OBIO Stock News & Catalysts – Orchestra BioMed

FEATURED

Orchestra BioMed Announces Pricing of Public Offering

NEW HOPE, Pa., Nov. 05, 2026 (GLOBE NEWSWIRE) -- Orchestra BioMed Holdings, Inc. (NASDAQ:OBIO) ("Orchestra BioMed" or the "Company"), a biomedical innovation company accelerating high-impact

Summary

Nov 5, 2026, 10:42 PM ·Globe Newswire

RECENT

Orchestra BioMed Announces Proposed Public Offering

NEW HOPE, Pa., Nov. 05, 2026 (GLOBE NEWSWIRE) -- Orchestra BioMed Holdings, Inc. (NASDAQ:OBIO) ("Orchestra BioMed" or the "Company"), a biomedical innovation company accelerating high-impact

Nov 5, 2026, 4:01 PM ·Globe Newswire

Orchestra BioMed Announces Virtue SAB Presentation at TCT 2026

Presentation will highlight Virtue SAB’s fundamentally different approach of infusing a large liquid volume of proprietary extended-release SirolimusEFR™ directly into and throughout the vessel wall.Virtue SAB’s

Oct 29, 2026, 8:30 AM ·Globe Newswire

Orchestra BioMed to Host R&D Day Featuring Clinical Insights and Development Plans for AVIM Therapy and Virtue® SAB

NEW HOPE, Pa., Oct. 22, 2026 (GLOBE NEWSWIRE) -- Orchestra BioMed Holdings, Inc. (NASDAQ:OBIO, "Orchestra BioMed" or the "Company")), a biomedical company accelerating high-impact technologies to

Oct 22, 2026, 8:30 AM ·Globe Newswire

Orchestra BioMed Exceeds Full Enrollment Target in the BACKBEAT Global Pivotal Trial of AVIM Therapy

330 patients randomized as of September 30, 2026, surpassing full trial enrollment targetCompany reiterates prior guidance: primary endpoint data to be submitted for late-breaking presentation consideration at a major

Oct 1, 2026, 8:00 AM ·Globe Newswire

Orchestra BioMed Announces AVIM Therapy to Be Featured in Two Sessions at HRX Live 2026

NEW HOPE, Pa., Sept. 16, 2026 (GLOBE NEWSWIRE) -- Orchestra BioMed Holdings, Inc. (NASDAQ:OBIO) ("Orchestra BioMed" or the "Company"), a biomedical company accelerating high-impact technologies to

Sep 16, 2026, 8:30 AM ·Globe Newswire

Orchestra BioMed Receives $6.1 Million Milestone Payment from Acquisition of Vivasure by Haemonetics

Payment follows approximately $5 million received in January 2026, bringing total cash proceeds received to approximately $11 millionCompany remains eligible for up to approximately $10 million in additional proceeds

Sep 15, 2026, 8:30 AM ·Globe Newswire

Orchestra BioMed Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

NEW HOPE, Pa., Sept. 02, 2026 (GLOBE NEWSWIRE) -- Orchestra BioMed Holdings, Inc. (NASDAQ:OBIO) ("Orchestra BioMed" or the "Company"), a biomedical company accelerating high-impact technologies to

Sep 2, 2026, 4:05 PM ·Globe Newswire

Orchestra BioMed to Participate in the H.C. Wainwright 28th Annual Global Investment Conference

NEW HOPE, Pa., Aug. 27, 2026 (GLOBE NEWSWIRE) -- Orchestra BioMed Holdings, Inc. (NASDAQ:OBIO, "Orchestra BioMed" or the "Company")), a biomedical company accelerating high-impact technologies to

Aug 27, 2026, 8:30 AM ·Globe Newswire

Orchestra BioMed to Participate in the Wells Fargo 21st Annual Healthcare Conference

NEW HOPE, Pa., Aug. 20, 2026 (GLOBE NEWSWIRE) -- Orchestra BioMed Holdings, Inc. (NASDAQ:OBIO, "Orchestra BioMed" or the "Company")), a biomedical company accelerating high-impact technologies to

Aug 20, 2026, 8:30 AM ·Globe Newswire

Orchestra BioMed Reports Second Quarter 2026 Financial Results and Highlights Recent Business Updates

The BACKBEAT global pivotal trial ("BACKBEAT Trial"), conducted in collaboration with Medtronic, is on track to reach its target of 284 evaluable randomized patients by end of Q3 2026, with primary data

Aug 10, 2026, 4:12 PM ·Globe Newswire

Orchestra BioMed Joins Russell 3000® and Russell 2000® Indexes

NEW HOPE, Pa., June 29, 2026 (GLOBE NEWSWIRE) -- Orchestra BioMed Holdings, Inc. (NASDAQ:OBIO) ("Orchestra BioMed" or the "Company"), a biomedical company accelerating high-impact technologies to

Jun 29, 2026, 8:00 AM ·Globe Newswire

Sidoti Events, LLC's June Small-Cap Virtual Conference

NEW YORK, NY / ACCESS Newswire / June 16, 2026 / Sidoti Events, LLC, an affiliate of Sidoti & Company, LLC, has released the presentation schedule and weblinks for its two-day June Small-Cap Virtual Investor Conference

Jun 16, 2026, 10:00 AM ·ACCESS Newswire

Orchestra BioMed Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

NEW HOPE, Pa., June 02, 2026 (GLOBE NEWSWIRE) -- Orchestra BioMed Holdings, Inc. (NASDAQ:OBIO) ("Orchestra BioMed" or the "Company"), a biomedical company accelerating high-impact technologies to patients through

Jun 2, 2026, 4:05 PM ·Globe Newswire

Orchestra BioMed to Participate in the Jefferies Global Healthcare Conference

NEW HOPE, Pa., May 19, 2026 (GLOBE NEWSWIRE) -- Orchestra BioMed Holdings, Inc. (NASDAQ:OBIO, "Orchestra BioMed" or the "Company")), a biomedical company accelerating high-impact technologies to patients through

May 19, 2026, 8:30 AM ·Globe Newswire

Orchestra BioMed Holdings, Inc. OBIO · News